Your browser doesn't support javascript.
loading
Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition.
Bradbury, Kathryn E; Appleby, Paul N; Tipper, Sarah J; Travis, Ruth C; Allen, Naomi E; Kvaskoff, Marina; Overvad, Kim; Tjønneland, Anne; Halkjaer, Jytte; Cervenka, Iris; Mahamat-Saleh, Yahya; Bonnet, Fabrice; Kaaks, Rudolf; Fortner, Renée T; Boeing, Heiner; Trichopoulou, Antonia; La Vecchia, Carlo; Stratigos, Alexander J; Palli, Domenico; Grioni, Sara; Matullo, Giuseppe; Panico, Salvatore; Tumino, Rosario; Peeters, Petra H; Bueno-de-Mesquita, H Bas; Ghiasvand, Reza; Veierød, Marit B; Weiderpass, Elisabete; Bonet, Catalina; Molina, Elena; Huerta, José M; Larrañaga, Nerea; Barricarte, Aurelio; Merino, Susana; Isaksson, Karolin; Stocks, Tanja; Ljuslinder, Ingrid; Hemmingsson, Oskar; Wareham, Nick; Khaw, Kay-Tee; Gunter, Marc J; Rinaldi, Sabina; Tsilidis, Konstantinos K; Aune, Dagfinn; Riboli, Elio; Key, Timothy J.
Affiliation
  • Bradbury KE; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Appleby PN; National Institute for Health Innovation, School of Population Health, The University of Auckland, Auckland, New Zealand.
  • Tipper SJ; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Allen NE; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Kvaskoff M; Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Overvad K; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Tjønneland A; Gustave Roussy, Villejuif, France.
  • Halkjaer J; Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
  • Cervenka I; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Mahamat-Saleh Y; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Bonnet F; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Kaaks R; Gustave Roussy, Villejuif, France.
  • Fortner RT; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Boeing H; Gustave Roussy, Villejuif, France.
  • Trichopoulou A; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • La Vecchia C; Gustave Roussy, Villejuif, France.
  • Stratigos AJ; CHU Rennes, Université de Rennes 1, Rennes, France.
  • Palli D; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Grioni S; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Matullo G; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
  • Panico S; Hellenic Health Foundation, Athens, Greece.
  • Tumino R; Hellenic Health Foundation, Athens, Greece.
  • Peeters PH; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Bueno-de-Mesquita HB; Hellenic Health Foundation, Athens, Greece.
  • Ghiasvand R; 1st Department of Dermatology and Venereology, National and Kapodistrian University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece.
  • Veierød MB; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, ISPRO, Florence, Italy.
  • Weiderpass E; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bonet C; Department of Medical Sciences, University of Torino, Torino, Italy.
  • Molina E; Italian Institute for Genomic Medicine (IIGM/fka HuGeF), Torino, Italy.
  • Huerta JM; Dipartmento di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy.
  • Larrañaga N; Cancer Registry and Histopathology Department, "Civic - M.P. Arezzo" Hospital, ASP, Ragusa, Italy.
  • Barricarte A; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Merino S; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, St Mary's Campus, W2 1PG, London, United Kingdom.
  • Isaksson K; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
  • Stocks T; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Ljuslinder I; Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway.
  • Hemmingsson O; Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway.
  • Wareham N; Department of Community Medicine, Faculty of Health Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.
  • Khaw KT; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Gunter MJ; Genetic Epidemiology Group, Folkhälsan Research Center and Faculty of Medicine, University of Helsinki, Finland.
  • Rinaldi S; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Tsilidis KK; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Aune D; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs, GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
  • Riboli E; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Key TJ; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Int J Cancer ; 144(5): 957-966, 2019 03 01.
Article in En | MEDLINE | ID: mdl-30191956
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin-Like Growth Factor I / Nutritional Status / Melanoma Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Cancer Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin-Like Growth Factor I / Nutritional Status / Melanoma Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Cancer Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United States